SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors closely monitor a high-stakes legal dispute with Nippon Shinyaku regarding the distribution rights for its Duchenne muscular dystrophy therapy, Deramiocel. The community is actively discussing the impact of this litigation on the upcoming August PDUFA date, with many bullish investors framing the lawsuit as a strategic catalyst that could return full commercial rights to Capricor ahead of the drug's anticipated approval.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as retail investors react to a combination of workforce restructuring, record-breaking trading volumes, and bullish anticipation for new revenue streams like AI-driven trading tools and prediction markets. Community members are actively debating the stock's potential for a breakout, with many focusing on the impact of increased platform engagement during major sporting and market events.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant institutional interest as the community anticipates imminent Phase 3 52-week data, which is widely viewed as a major catalyst for potential M&A activity. Traders are actively discussing the stock's tight float and the strategic significance of recent supply agreements alongside upcoming conference presentations.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is experiencing heightened trading volume and volatility as investors speculate on potential data center tenant agreements amid ongoing boardroom leadership conflicts. Community sentiment remains polarized, with some traders optimistic about the company's energy infrastructure assets while others are wary of the persistent management drama and the lack of confirmed commercial contracts.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant investor friction as stakeholders express frustration over stagnant stock performance and perceived management inertia, despite ongoing clinical progress and established revenue streams. Community discussion is heavily centered on the company's valuation gap compared to sector peers, with many calling for a potential buyout or leadership change to catalyze a long-awaited recovery.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is surging after the FDA reversed its previous stance and now allows the company to use three-year Phase I/II data for an accelerated approval BLA filing, effectively pulling forward the commercialization timeline for its Huntington's disease gene therapy. The community is actively discussing the significant regulatory win and the potential for a rapid re-rating, with traders highlighting the strategic importance of the ClearPoint navigation system to the procedural rollout.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

LABD is experiencing heightened trading activity as the community remains divided over whether to capitalize on the biotech sector's volatility through short-term scalp trades or hold despite significant losses from the ETF's prolonged decline. Discussions are centered on the upcoming influence of key economic figures like Kevin Warsh, the impact of XBI's technical channel breakouts, and the recurring behavioral patterns traders are attempting to exploit during this period of market uncertainty.

Arqit Quantum, Inc. engages in the provision of cybersecurity services via satellite and terrestrial forms. Its product is QuantumCloud which secures devices with cloud-based quantum encryption. The company was founded by David John Williams and David James Bestwick on April 26, 2021 and is headquartered in London, the United Kingdom.

Arqit Quantum Inc

Arqit Quantum is experiencing significant momentum as investors pivot toward quantum-safe cybersecurity, with the stock drawing attention for its low float and heavy institutional ownership. The community is actively discussing its potential for a parabolic squeeze, citing recent partnerships and the critical industry demand for post-quantum cryptographic solutions.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF is trending as investors rotate back into the sector, bolstered by a wave of M&A activity and positive data readouts for key oncology therapies. The community is actively discussing the potential for a sustained breakout, while closely monitoring clinical trial milestones and regulatory updates that act as primary catalysts for the ETF's performance.

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Carmax Inc

CarMax is facing significant investor scrutiny after reporting a major earnings miss and signaling weak sales, leading some to question the company's turnaround strategy amidst a challenging used-vehicle market. While activists push for leadership and operational changes to improve efficiency, the community remains deeply divided between those viewing the current valuation as a deep-value opportunity and others anticipating further downside due to lingering economic headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EXLS vs. NOW: Which Stock Is the Better Value Option?

Lifemed and EXL to Transform Healthcare Revenue Cycle Management into Revenue Cycle Automation

Lifemed and EXL to Transform Healthcare Revenue Cycle Management into Revenue Cycle Automation Lifemed and EXL to Transform Healthcare Revenue Cycle Management into Revenue Cycle Automation PR Newswire MIAMI, June 8, 2026 MIAMI, June 8, 2026 /PRNewswire/ -- Paying healthcare providers is far from...

BetterInvesting Magazine Update on Netflix (NASDAQ: NFLX) and ExlService Holdings Inc. (NASDAQ: EXLS)

BetterInvesting Magazine Update on Netflix (NASDAQ: NFLX) and ExlService Holdings Inc. (NASDAQ: EXLS) BetterInvesting Magazine Update on Netflix (NASDAQ: NFLX) and ExlService Holdings Inc. (NASDAQ: EXLS) PR Newswire TROY, Mich., May 22, 2026 TROY, Mich., May 22, 2026 /PRNewswire/ -- Netflix Inc's...

Innodata Stock Soars 97% Since Q1 Earnings: Buy, Hold or Take Profit?

INOD shares have nearly doubled since Q1 results, as revenues jump 54% and guidance is raised. Meanwhile, a lofty 73.4x forward P/E has investors weighing profit-taking.

Innodata Before Q1 Earnings: Should You Buy, Sell or Hold the Stock?

INOD heads into Q1 results with strong generative AI demand, but project timing and investment pressures could keep earnings uneven.

Vanguard Group Inc. Has $605.14 Million Stock Holdings in ExlService Holdings, Inc. $EXLS

Vanguard Group Inc. decreased its position in shares of ExlService Holdings, Inc. (NASDAQ:EXLS - Free Report) by 2.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,258,782 shares of the business services...

ExlService (NASDAQ:EXLS) Raised to "Strong-Buy" at Barrington Research

Barrington Research upgraded shares of ExlService from a "hold" rating to a "strong-buy" rating in a research note on Thursday...

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for ExlService (NASDAQ:EXLS) Stock

JPMorgan Chase & Co. increased their price objective on ExlService from $42.00 to $43.00 and gave the stock an "overweight" rating in a research note on Thursday...

Innodata vs. ExlService: Which AI Data Stock Is the Better Buy?

INOD's faster growth and generative AI focus face off against EXLS' scale and stability. Let's discuss which AI data stock has the edge now.

ExlService Q1 Earnings Call Highlights

Executives at ExlService (NASDAQ:EXLS) told investors the company opened 2026 with strong momentum, driven by growing adoption of AI across regulated industries and a continued shift in its revenue...

ExlService Holdings, Inc. is an operations management and analytics company, which engages in providing business process management. It operates through the following segments: Insurance, Healthcare, Travel, Transportation, and Logistics, Finance and Accounting, Analytic, and All Other. The Insurance segment serves property and casualty insurance, life insurance, disability insurance, annuity, and retirement services companies. The Healthcare segment offers services related to care management or population health, payment integrity, revenue optimization, and customer engagement. The Travel, Transportation, and Logistics segment includes business processes in corporate and leisure travel such as reservations, customer service, fulfillment, and finance and accounting. The Finance and Accounting segment is comprised of procure-to-pay, order-to-cash, hire-to-retire, record-to-report, regulatory reporting, financial planning and analysis, audit and assurance, treasury, and tax processes. The Analytics segment consists of driving improved business outcomes for customers by generating data-driven insights. The All-Other segment is involved in banking, financial, utilities, and consulting services. The company was founded by Vikram Talwar and Rohit Kapoor in April 1999 and is headquartered in New York, NY.

ExlService Holdings Inc

EXL Expands Alliance With Databricks to Boost GenAI Migration Tools: But Retail Remains Cautious

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

EXLSExlservice Hldgs Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EXLS News